Companies / South Africa
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
Enaleni Rose To The Challenge In 2007
March 2008 | Company News AlertSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
In the company's own words, Enaleni's recently released annual results for the year ending December 31 2007 were 'reasonable, under the circumstances'. BMI would agree with this assessment. Revenues increased by 19% over the course of the year to reach ZAR940.7mn (US$117mn). While the explosive sales growth of previous years was not repeated in 2007, any growth can be taken as a positive from what most observers would describe as the most challenging year in the company's short